Tradestie Institutional Equity Comparison Engine

ILCG vs IMCG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IMCG Overall Edge

IMCG Captures Institutional Edge (1โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to iShares Morningstar Mid-Cap Growth ETF (IMCG) driven by superior Momentum & Technical. Fundamentally, ILCG trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus IMCG at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ILCG sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro) against IMCG sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ILCG N/M vs IMCG N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner IMCG
1Y +1.1% vs +13.9% ยท 52W Pos 44% vs 62%
Options & Structure Winner Tie
UNCLASSIFIED (2nd %ile IV) vs UNCLASSIFIED (2nd %ile IV)
ILCG NYSE Arca
iShares Morningstar Growth ETF
Institutional Equity
$104.49
-2.9% 1D
Market Cap N/A
1M Return -7.56%
1Y Return +1.06%
Forward P/E N/M
Unified AI Score
53.7 / 100 HOLD
Tech 54.0 Fund 60.0 Flow 50.0 Mom 60.0
IMCG NYSE Arca
iShares Morningstar Mid-Cap Growth ETF
Institutional Equity
$91.30
-2.05% 1D
Market Cap N/A
1M Return -2.43%
1Y Return +13.88%
Forward P/E N/M
Unified AI Score
43.9 / 100 HOLD
Tech 47.0 Fund 60.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ILCG +1.06% IMCG +13.88% Spread: +12.82 pp (IMCG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ILCG TTM Op. Margin: N/A IMCG TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ILCG vs IMCG. Trailing 12-month operating profitability (ILCG N/A vs IMCG N/A) and valuation multiples (ILCG N/M vs IMCG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ILCG (1) vs IMCG (2)
Institutional Metric ILCG IMCG Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 44% ($91โ€“$121) 62% ($76โ€“$101) Stronger Trend IMCG
Beta / 30D Volatility Risk Regime 1.46ฮฒ ยท 33% Vol 1.20ฮฒ ยท 27% Vol Lower Realized Risk IMCG
Unified Institutional Score Composite Signal 53.7 / 100 (HOLD) 43.9 / 100 (HOLD) Higher Composite ILCG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ILCG vs IMCG Buy Guide
ILCG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live ILCG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IMCG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live IMCG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ILCG nor IMCG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.